MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Levi & Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
August 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
August 11, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Exponent (EXPO) Q2 Revenue Rises 1%
Via The Motley Fool
Topics Artificial Intelligence Product Recall
Tickers EXPO
Exposures Artificial Intelligence Legal Product Safety
Alnylam's Amvuttra Makes Powerful Entrance, Eyes First-Line Dominance
Via Benzinga
Tickers ALNY
Exposures Product Safety
What Are the Must-Have Certifications for Medical Heat Exchangers?
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients
Via Benzinga
Tickers NVO SNY
Exposures Product Safety
LENZ Therapeutics' Eye Drop Scores First FDA Approval For Age-Related Blurred Vision Condition Impacting 128 Million People
Via Benzinga
Tickers LENZ
Exposures Product Safety
iRhythm (IRTC) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Law Enforcement World Trade
Tickers IRTC
Exposures Financial Legal Product Safety
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
Via Benzinga
Tickers NVO REGN SNY
Exposures Product Safety
2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now
Via The Motley Fool
Tickers LULU VRTX
Exposures Product Safety
AtrendLtd Launches "Investing in Medical Innovation" Initiative to Accelerate Healthcare Transformation
Via 24-7 Press Release
Tickers PFE
Exposures Product Safety
Retail Buzz Surges For Apellis As Goldman Hikes Price Target After Solid Syfovre Sales, FDA Win For Kidney Drug
Via Stocktwits
Tickers APLS GS MS
Exposures Product Safety
International Process Solutions Expands Pipette Calibration Services Across California to Meet Growing Biotech Demand
Via AB Newswire
Exposures Product Safety
United Health Products Provides Regulatory Status Update
Via NewMediaWire
Tickers UEEC
Exposures Product Safety
United Health Products Provides Regulatory Status Update
Via TheNewswire.com
Tickers UEEC
Exposures Product Safety
Ibogaine by David Dardashti: Texas’ Landmark Psychedelics Investment Bolstered by Novel Ibogaine Microdosing Protocol Analysis
Via AB Newswire
Exposures Product Safety
BlackLabel Supplements Targets Sports Industry Safety with NSF-Certified for Sport Launch Across United States
Via PRUnderground
Exposures Product Safety
The Oligonucleotide Therapeutics Society Announces the 21st Annual Meeting in Budapest, Hungary
Via Press Release Distribution Service
Exposures Product Safety
REPL LAWSUIT ALERT: Levi & Korsinsky Notifies Replimune Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Contact Levi & Korsinsky by September 15, 2025 Deadline to Join Class Action Against Capricor Therapeutics, Inc. (CAPR)
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
REPL LAWSUIT ALERT: Levi &amp; Korsinsky Notifies Replimune Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Contact Levi &amp; Korsinsky by September 15, 2025 Deadline to Join Class Action Against Capricor Therapeutics, Inc. (CAPR)
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky for More Information - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Lenz (LENZ) Q2 Revenue Jumps 604%
Via The Motley Fool
Tickers LENZ
Exposures Product Safety
APELLIS PHARMACEUTICALS INC (NASDAQ:APLS) Reports Mixed Q2 2025 Results with EPS Beat and Revenue Miss
Via Chartmill
Tickers APLS
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
TOP
Email a Story